Fate Therapeutics (FATE) Operating Expenses (2016 - 2025)
Historic Operating Expenses for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to $36.5 million.
- Fate Therapeutics' Operating Expenses fell 3421.94% to $36.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $181.9 million, marking a year-over-year decrease of 1341.68%. This contributed to the annual value of $223.9 million for FY2024, which is 1186.29% down from last year.
- Fate Therapeutics' Operating Expenses amounted to $36.5 million in Q3 2025, which was down 3421.94% from $38.9 million recorded in Q2 2025.
- In the past 5 years, Fate Therapeutics' Operating Expenses registered a high of $108.8 million during Q4 2022, and its lowest value of $36.5 million during Q3 2025.
- In the last 5 years, Fate Therapeutics' Operating Expenses had a median value of $60.2 million in 2021 and averaged $67.0 million.
- In the last 5 years, Fate Therapeutics' Operating Expenses surged by 7632.99% in 2021 and then tumbled by 5426.25% in 2023.
- Quarter analysis of 5 years shows Fate Therapeutics' Operating Expenses stood at $86.5 million in 2021, then grew by 25.82% to $108.8 million in 2022, then plummeted by 54.26% to $49.8 million in 2023, then grew by 27.85% to $63.6 million in 2024, then crashed by 42.66% to $36.5 million in 2025.
- Its Operating Expenses was $36.5 million in Q3 2025, compared to $38.9 million in Q2 2025 and $42.9 million in Q1 2025.